業績 (5)
Effect of healthy lifestyle on renal dysfunction risk: interactions with genetic risk
Takase M; Nakaya N; Kogure M; Hatanaka R; Nakaya K; Chiba I; Tokioka S; Nochioka K; Nakamura T; Tsuchiya N; Hirata T; Kanno I; Narita A; Obara T; Ishikuro M; Ohseto H; Takahashi I; Uruno A; Kobayashi T; Kodama EN; Hamanaka Y; Orui M; Ogishima S; Nagaie S; Fuse N; Sugawara J; Kuriyama S; Matsuda K; Izumi Y; Kinoshita K; Tamiya G; Hozawa A; Yamamoto M
Clinical kidney journal
Predictive value of the polygenic risk score for developing epilepsy: a systematic review and meta-analysis
Kubota T; Ngadimon IW; Ohseto H; Viswanathan S; Ravat P; Acharya MK; Kuroda N; Konomatsu K; Obara T; Jin K; Aoki M; Nakasato N
Epilepsy & behavior: E&B
Associations of family history of hypertension, genetic, and lifestyle risks with incident hypertension
Takase M; Hirata T; Nakaya N; Kogure M; Hatanaka R; Nakaya K; Chiba I; Tokioka S; Nochioka K; Nakamura T; Tsuchiya N; Metoki H; Satoh M; Narita A; Obara T; Ishikuro M; Ohseto H; Takahashi I; Kobayashi T; Kodama EN; Hamanaka Y; Orui M; Ogishima S; Nagaie S; Fuse N; Sugawara J; Kuriyama S; Tamiya G; Hozawa A; Yamamoto M
Hypertension Research
Association of circulating metabolites and polygenic risk score with incident type 2 diabetes: a prospective community-based cohort study
Takase M; Nakaya N; Kogure M; Hatanaka R; Nakaya K; Chiba I; Tokioka S; Nochioka K; Nakamura T; Tsuchiya N; Hirata T; Koshiba S; Kumada K; Motoike I; Hishinuma E; Narita A; Obara T; Ishikuro M; Ohseto H; Takahashi I; Kobayashi T; Kodama EN; Hamanaka Y; Orui M; Ogishima S; Nagaie S; Fuse N; Sugawara J; Kuriyama S; Matsuda K; Izumi Y; Ohneda K; Kinoshita K; Hozawa A; Yamamoto M; Biobank Japan Project; ToMMo investigators
Cardiovascular diabetology
Preeclampsia prediction with maternal and paternal polygenic risk scores: the TMM BirThree Cohort Study
Ohseto H; Ishikuro M; Obara T; Narita A; Takahashi I; Shinoda G; Noda A; Murakami K; Orui M; Iwama N; Kikuya M; Metoki H; Sugawara J; Tamiya G; Kuriyama S
Scientific reports
ブログ記事 (3)
臨床研究者のゲノム研究 ─ PRS QC解説
ポリジェニックリスクスコア(PRS)作成に必要なQC手順を、ベースデータ・ターゲットデータ別に解説。Nature Protocols 2020年のチュートリアルに準拠した実践的ガイドです。
臨床研究者のゲノム研究 ─ GWASの活かし方
GWASの基本から、ポリジェニックリスクスコア(PRS)やメンデリアンランダマイゼーション(MR)といった応用手法まで、臨床研究者がゲノム研究を活かすための実践的ガイドを解説します。
疾患リスク予測をどう生かすか ─ 疫学と予防医学の視点
疾患リスク予測はなぜ必要なのか?因果推論との違いを整理し、予測モデルが臨床・政策で意味を持つ3つの条件を疫学者の視点から考察するシリーズ第1回。